Setting up a regional expert panel for complex colorectal polyps - 14/06/22
on behalf of the
Expert Panel Group∗
Abstract |
Background and Aims |
Advanced endoscopic resection techniques for complex colorectal polyps have evolved significantly over the past decade, leading to a management shift from surgical to endoscopic resection as the preferred treatment. However, in practice, interhospital consultation and appropriate referral management remain challenging, leading to unnecessary surgical resections. To support regional care for patients with complex colorectal polyps, facilitate peer consultations, and lower thresholds for referrals, an expert panel consultation platform was initiated in the northwestern region of the Netherlands.
Methods |
We initiated a regional expert panel in the northwestern region of the Netherlands for patients with complex colorectal polyps and studied the implementation, adaption, and clinical impact. All panel consultations between June 2019 and May 2021 were retrospectively analyzed, and user satisfaction among panel members was evaluated.
Results |
Eighty-eight patients with complex colorectal polyps from 11 of 15 participating centers (73.3%) were discussed in our panel. The most common reason for panel consultation was suspicion of invasive cancer in 36.4% (n = 32). After panel consultation, 43.2% of the consulting endoscopists (n = 38) changed their initial treatment strategy, and in 63.6% (n = 56) patients were referred to another endoscopy center. Of 26 cases submitted with a primary proposal for surgical treatment, surgery was avoided in 7 (26.9%). User satisfaction was rated high in most participating centers (91.7%).
Conclusions |
Our study shows that implementation of and consultation with a regional expert panel can be a valuable tool for endoscopists to guide and optimize treatment of complex colorectal polyps and facilitate interhospital referrals in a regional network.
Le texte complet de cet article est disponible en PDF.Graphical abstract |
Abbreviations : CRC, eFTR, ESD, SMSA
Plan
| DISCLOSURE: The following authors disclosed financial relationships: B. A. J. Bastiaansen: Speaker for Olympus, Tillotts Pharma AG, and Ovesco Endoscopy. E. Dekker: Research support and equipment loan from FujiFilm; consultant for FujiFilm, Olympus, Tillotts Pharma AG, GI Supply, CPP-FAP, and PAION; speaker for Olympus, Roche, GI Supply, Ambu, and Ipsen. P. Fockens: Consultant for Cook, Ethicon, and Olympus; research support from Boston Scientific. All other authors disclosed no financial relationships. |
|
| If you would like to chat with an author of this article, you may contact Dr Fockens at p.fockens@amsterdamumc.nl. |
Vol 96 - N° 1
P. 84 - juillet 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
